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Abstract
Background: To analyze differences of access-site complications related to the height of femoral arterial puncture
and the use of a vascular closure device (VCD) following percutaneous coronary intervention (PCI).
Methods: A subgroup of the FERARI study being treated by femoral arterial access and valuable inguinal angiography
before implantation of a VCD were included. Inguinal angiographies were systematically reviewed by two independent
cardiologists to determine the correct height of femoral arterial puncture. Bleeding complications were documented
within 30 days after PCI and were categorized according to BARC, TIMI, GUSTO and FERARI classifications.
Results: Femoral access point imaging was available in 95 patients compared to 105 patients without. The common
femoral artery (CFA) was the most accessed artery in 41%, followed by the femoral arterial bifurcation (39%) and lower
access sites distally from the femoral arterial bifurcation (low puncture: 20%). No differences were observed regarding
indication of PCI, procedural data and anticoagulation therapies in relation to the heights of femoral arterial access
(p > 0.05). Despite using VCD, arterial puncture at the CFA resulted in numerically highest numbers of overall bleedings
(62%) compared to femoral arterial bifurcation (41%) (p = 0.059). 58% of bleedings occurred after arterial puncture
below the femoral bifurcation (low puncture). Though no significant differences of bleedings regarding classifications
of BARC, GUSTO, TIMI and FERARI as well as other vascular endpoints were observed regarding puncture height.
Conclusions: The present analysis demonstrates no significant differences of bleeding complications in relation to the
height of femoral arterial puncture and subsequent use of a VCD.
Keywords: Bleeding, Vascular closure device, Femoral artery
Background
Bleedings are a common complication of percutaneous
coronary interventions (PCI) both affecting the arterial
access site and occurring in terms of general outcome.
Bleedings do not only affect patients’ satisfaction, but do
also increase mortality [1]. With specific regard to fem-
oral arterial access-site bleedings, different strategies
have been evaluated in order to reduce them. Besides
manual compression and application of pressure ban-
dages around the hips, so called vascular closure devices
(VCD) were developed in the early 1990’s [2]. VCD were
shown to reduce access-site bleedings and to reduce post
interventional time to hemostasis [3, 4]. In contrast non-
access site bleedings are supposed to result in a higher
mortality risk compared to bleedings from primary ac-
cess site [5]. Vavalle et al. showed in-hospital bleedings
in acute coronary syndrome (ACS) patients to be associ-
ated with an increased risk of death, whereas mild
access-site bleedings were not [6].
VCD have entered the medial practice in modern
cardiac catheterization laboratories [3, 7]. Additionally
this treatment has proven advantageous on the
patients’ overall satisfaction and mobilization [8].
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Different characteristics were shown to predict arterial
access-site complications after PCI, such as advanced
age, female sex, bleeding predispositions or renal fail-
ure [9, 10]. However, there is no evidence currently
available on how the height of femoral arterial punc-
ture alters the occurrence of PCI-related bleedings.
Therefore, this sub-study of the FERARI trial [11, 12]
aims to evaluate the differences of PCI-related bleedings
depending on the height of femoral arterial puncture in
combination with the treatment of a VCD.
Methods
Study patients and data collection
The present study is based on a subset of patients from
the “Femoral Closure versus Radial Compression
Devices Related to Percutaneous Coronary Interventions
Fig. 1 Flow chart illustrating the selection of patients for the present sub-analysis of the FERARI study
Fig. 2 Topographic scheme demonstrating the different heights of femoral arterial puncture as well as the distribution of puncture rates being
evaluated from inguinal angiographies following PCI. Puncture rates are presented as n (%)
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(FERARI)” study. The FERARI study is a single-center
prospective, nonrandomized observational study being
performed at the First Department of Medicine, Univer-
sity Medical Centre Mannheim (UMM) in Mannheim,
Germany (clinicaltrials.gov identifier: NCT02455661).
The study was approved by the medical ethics commis-
sion II of the Faculty of Medicine Mannheim, University
of Heidelberg, Germany. Written informed consent is
obtained from all participating patients or their legal
representatives [11]. Briefly, those patients with a valu-
able inguinal angiography before successful implantation
of the AngioSealTM femoral VCD (Angio-Seal™; St. Jude
Medical, Inc., St Paul, USA) following PCI were in-
cluded. Patients with radial PCI and patients with a fem-
oral PCI without any or a valuable inguinal angiography
were excluded (Fig. 1). Performing femoral angiography
belonged to the operators’ discretion and was performed
to verify the location of puncture above or below the
epigastric artery, to detect severe calcification of the
puncture site or to alleviate difficult femoral or aortic
passing.
Standardized angiography was performed from left anter-
ior oblique (LAO) 30° and right anterior oblique (RAO) 30°
view. A valuable inguinal angiography was defined, when
the entire inguinal anatomy of the iliac and femoral arteries
was documented, including the femoral bifurcation. All an-
giographies were systematically reviewed on the “OsiriX Im-
aging Software” (Pixmeo SARL, Switzerland) by two
independent cardiologists in order to determine the correct
height of femoral arterial puncture.
Femoral arterial puncture was performed by standardized
Seldinger technique in all patients using a conventional
stainless steel puncture needle (SFM Medical Devices©,
Wächtersbach, Germany) (i.e. no micropuncture needle).
Ultrasound guiding during arterial puncture or concomi-
tant ipsilateral venous or arterial access was excluded.
Number of needle passes was not documented, but was re-
stricted to a maximum number of 5 in cases of difficult
anatomy or calcification. The allowed French size in the
FERARI study was 5–6 French. Only four different experi-
enced interventional cardiologists performed PCIs in this
study with a minimum volume of 300 PCI cases per year
Table 1 Baseline characteristics of the study population
All patients
(n = 95)
Common femoral artery
(n = 39)
Femoral bifurcation
(n = 37)
Low puncture
(n = 19)
p value
Age, mean ± SD 69.3 ± 10.5 67 ± 10.6 70.7 ± 9.7 71.4 ± 11.4 0.142
BMI, mean ± SD 28.3 ± 5.6 26.4 ± 3.7 29.5 ± 7.2 29.6 ± 4.9 0.038
Male, n (%) 61 (64) 31 (80) 23 (64) 7 (37) 0.006
Cardiovascular risk factors, n (%)
Arterial hypertension 71 (75) 26 (67) 31 (86) 14 (74) 0.228
Diabetes 34 (35) 9 (23) 16 (44) 9 (47) 0.089
Smoking 16 (17) 10 (26) 3 (8) 3 (16) 0.118
Cardiac family history 12 (13) 3 (8) 6 (16) 3 (16) 0.484
Prior medical history, n (%)
Congestive heart failure 12 (13) 5 (13) 5 (14) 2 (11) 0.922
Coronary artery disease 46 (48) 16 (41) 20 (54) 10 (53) 0.482
Peripheral artery disease 6 (6) 3 (8) 2 (5) 1 (5) 1.000
Chronic kidney disease 21 (22) 5 (13) 10 (27) 6 (32) 0.159
Indication for PCI, n (%)
STEMI 6 (6) 2 (5) 2 (5) 2 (11) 0.741
NSTEMI 27 (28) 12 (31) 11 (30) 4 (21) 0.726
Unstable AP 19 (20) 9 (24) 6 (16) 4 (21) 0.748
Stable AP 19 (20) 6 (15) 8 (21) 5 (26) 0.592
Other 24 (25) 10 (26) 10 (27) 4 (21) 0.887
Procedural data
Average Time 47 52 51 50
Drug eluting stents, n (%) 85 (90) 35 (90) 33 (89) 17 (90) 1.000
Bare metal stents, n (%) 4 (4) 1 (3) 2 (5) 1 (5) 0.836
Total stent length, mean ± SD 42.4 ± 29.7 39.5 ± 24.8 42.3 ± 31.7 48.3 ± 30.6 0.561
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and an equal distribution of experiences with both the ra-
dial and femoral approach of each operator. Operators had
already implanted at least 100 AngioSeal© femoral closure
devices per year. All operators were equally experienced in
both radial and femoral accessed interventions [11].
Definition of height of femoral arterial puncture based on
anatomical description
The procedural X-ray contrast angiography of the fem-
oral arteries was reviewed systematically and the access
point was described anatomically. Arterial parts were
classified into the external iliac artery (EIA), common
femoral artery (CFA), femoral bifurcation, profound fem-
oral artery (PFA) and superficial femoral artery (SFA).
Based on these anatomic landmarks 4 different puncture
heights were defined: high puncture at the EIA and
above the inguinal ligament, femoral puncture at the
CFA, femoral bifurcation and low puncture below the
femoral bifurcation either at the PFA or SFA.
The border between EIA and CFA was drawn at the
superficial epigastric artery as an indicator for the
localization of the inguinal ligament. The femoral bifur-
cation was described as the area of 1 cm into each prox-
imal and distal vessel branches. The PFA and SFA were
distinguished by the typical lateral projection of the prom-
inently visual course of the PFA and its side branches,
namely the lateral circumflex femoral artery and the med-
ial circumflex femoral artery.
Post interventional procedure
After successful PCI the VCD was implanted. Afterwards
a circumferential pressure bandage is added to the punc-
ture site to further support the prevention of bleedings.
Patients were advised to remain in lying position (i.e. bed-
rest) for 6 h. Pressure bandages were removed after a total
of 12 h, unless access site bleedings occurred. Patients
were not subject to early ambulation. All PCI patients
remained hospitalized for at least 24 h, early ambulation
was not allowed after PCI.
Outcome definition and follow-up
All patients were followed up during hospital stay and until
30-days after the index procedure directly and by standard-
ized telephone visits. The primary outcome was defined as
overall, access-site and non-access-site bleedings occurring
within 30-days of follow-up. Overall bleedings were defined
according to established bleeding classifications, i.e. “Bleed-
ing Academic Research Consortium” (BARC) score, “The
Thrombolysis in Myocardial infarction” (TIMI) score and
Table 2 Anticoagulation of patients with recorded bleedings during PCI
All patients
(n = 50)
Common femoral artery
(n = 24)
Femoral bifurcation
(n = 15)
Low puncture
(n = 11)
p value
Pre-PCI, n (%)
ASS 27 (54) 11 (46) 10 (67) 6 (55) 0.447
Clopiogrel 9 (18) 5 (21) 1 (7) 3 (27) 0.346
Ticagrelor 1 (2) 0 (0) 1 (7) 0 (0) 0.520
Prasugrel 5 (10) 1 (4) 3 (20) 1 (9) 0.284
LMH 2 (4) 0 (0) 1 (6) 1 (9) 0.265
NOAC/OAC 8 (16) 4 (17) 3 (20) 1 (9) 0.886
None 17 (34) 11 (46) 2 (13) 4 (36) 0.104
INR, mean ± SD 1.07 ± 0.23 1.09 ± 0.26 1 ± 0.08 1.16 ± 0.33 0.066
Peri-PCI, n (%)
Heparin 50 (100) 24 (100) 15 (100) 11 (100) 1
GP IIB/IIIA inhibitor 2 (4) 1 (4) 0 (0) 1 (9) 0.481
Bivalirudin 1 (2) 0 (0) 1 (7) 0 (0) 0.520
Post-PCI, n (%)
ASS + Clopidogrel 33 (66) 14 (58) 10 (67) 9 (82) 0.395
ASS + Ticagrelor 4 (8) 1 (4) 2 (13) 1 (9) 0.545
ASS + Presugrel 6 (12) 5 (21) 1 (7) 0 (0) 0.279
ASS + NOAC/OAC 0 (0) 0 (0) 0 (0) 0 (0) -
Thienopyridine + NOAC/OAC 3 (6) 1 (4) 2 (13) 0 (0) 0.432
Triple Therapy 4 (8) 3 (13) 0 (0) 1 (9) 0.424
LMH low molecular heparin, NOAC/OAC Warfarin or one of the new oral anticoagulants (Rivaroxaban, Dabigatran, Apixaban); Triple
therapy: ASS + Clopidogrel + NOAC/OAC
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the “Global Use of Strategies to Open Occluded Arteries”
(GUSTO) score [6, 13, 14]. Access site bleedings were de-
fined as hematomas, active bleedings, dissections,
pseudoaneurysms, arteriovenous fistula, retroperitoneal
hematoma and non-access-site bleeding. Access site bleed-
ings were classified according to the study-specific FERARI
classification, as described previously: [11] small (<5 cm),
intermediate (5–15 cm), large (>15 cm) hematomas and
complicated access-site bleedings.
Statistics
Statistical analyses were performed with SPSS Statistics
(IBM, Armonk, NY) and GraphPad Prism (GraphPad Soft-
ware, Inc., La Jolla, CA). Data are presented as medians
with interquartile ranges (25th and 75th percentiles) or as
total numbers with group-related percentages. Normal dis-
tribution of data was tested with the Kolmogorov-Smirnov
test. In case of normal distribution, the t-test was applied to
compare scaled data. Scaled variables not normally distrib-
uted were compared using the Mann–Whitney U test. Cat-
egorical variables were compared using the chi-squared
test, in case of low event rates the Fisher’s exact test was
used. Risk factors for access site bleedings, which were
shown to differ significantly between the two study groups,
were adjusted using uni- and multivariate linear regression
analyses for the predefined study outcomes representing
the dependent variable. Level of significance was set at p <
0.05 (two-tailed), a statistical trend was defined at p < 0.1
(two-tailed).
Results
Study population
As illustrated in Fig. 1, of the initial study cohort of 400 pa-
tients, final number of 95 patients revealed valuable inguinal
angiography as well as successful femoral PCI with a fem-
oral VCD and were included for the present sub-analysis.
Figure 2, illustrates the distribution of the different ar-
terial puncture sites. CFA was the most punctured arterial
site (41%), followed by the femoral bifurcation (39%) and
low puncture distally to the femoral bifurcation either at
the PFA or SFA (20%). High punctures above the inguinal
ligament were not performed within the present cohort.
Patient demographics were equally distributed between
groups (Table 1), with a mean age of 67 to 71 years. Pa-
tients were often male, being mostly present in all sub-
groups (80% in common femoral, 64% in femoral
bifurcation), despite in patients of the low puncture group
(37%) (p = 0.006). Body mass index (BMI) was higher in
femoral punctured patients compared to patients in the
low puncture groups (p = 0.038). No further significant
differences were found regarding cardiovascular risk fac-
tors between subgroups (Table 1). Accordingly the indica-
tions for PCI as well as mean procedural length or
implanted stent lengths did not differ significantly
(Table 1). The hospital stay time averaged at 9 days. Dur-
ing the 30 day follow-up period 11% of patients were
rehospitalized, 4% received additional coronary angiog-
raphy, while 3% received additional stent implantation.
One stent thrombosis was documented, which resulted in
the only death (1%).
Table 2 summarizes the different anticoagulant therapies
being administered for all spectated bleedings. Neither
pre-, peri- nor post-interventional combinations of anti-
coagulant therapies revealed any significant differences re-
lated to the different groups of arterial puncture height.
Bleedings related to the height of femoral arterial
puncture
Overall bleedings occurred in more than half of all pa-
tients (53%) with prior femoral angiography, which was
Table 3 Bleeding rates depending on the presence of femoral
angiography in PCI patients with a femoral VCD
Angiography
(n = 95)
No angiography
(n = 105)
p value
Overall bleedings, n (%) 50 (53) 61 (58) 0.437
Related to 5 F, ratio (%) 6/14 (43) 7/15 (47) 0.837
Related to 6 F, ratio (%) 44/81 (54) 54/90 (60) 0.453
BARC, n (%)
0 45 (48) 44 (42) 0.437
1 38 (40) 50 (48) 0.278
2 10 (11) 10 (10) 0.813
3A 0 (0) 1 (1) 1
3B 2 (2) 0 (0) 0.224
3C 0 (0) 0 (0) -
4 0 (0) 0 (0) -
5 0 (0) 0 (0) -
TIMI, n (%)
0 45 (47) 44 (42) 0.437
1 50 (53) 60 (57) 0.522
2 0 (0) 1 (1) 1
3 0 (0) 0 (0) -
GUSTO, n (%)
0 45 (47) 44 (42) 0.437
1 49 (52) 60 (57) 0
2 0 (0) 1 (1) 1
3 1 (1) 0 (0) 0.475
FERARI, n (%)
0 45 (47) 44 (42) 0.437
1 25 (26) 27 (26) 0.923
2 13 (14) 10 (10) 0.681
3 9 (10) 11 (10) 0.813
4 3 (3) 3 (3) 1
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not significantly different compared to patients without
femoral angiography (n = 105, overall bleeding rate 58%)
(p = 0.437) (Table 3). Most patients received 6 F intro-
ducer sheaths (femoral angiography: 85% versus 15%; no
femoral angiography: 95% versus 5%). No differences of
bleeding rates were found depending on the choice of
sheath size or presence of angiography (p > 0.05).
With regard to BARC, TIMI and GUSTO bleeding
classifications 52.6% patients received a score of 1 or
higher (Tables 3 and 4). Moderate bleedings (GUSTO 2)
did not develop, whereas a severe bleeding (GUSTO 3)
was only observed once (1.1%) in the common femoral
subgroup. Including all primary access site bleedings,
61.5% femoral punctured patients showed bleedings
(BARC, TIMI, GUSTO score ≥ 1). In the femoral bifur-
cation group bleedings were spectated in 41% patients,
low puncture showed 58% bleedings (Tables 3 and 4).
Mostly observed bleedings consisted of local hematomas
(FERARI class 1–3) in 49.5% patients. Complicated
access-site bleedings consisted of post-interventional
open bleedings (2.1%), AV-dissection (2.1%), aneurysm
spurium (1.1%).
Discussion
The present subanalysis of the FERARI study evaluates
differences of PCI-related bleedings depending on the
height of femoral arterial puncture in combination with
the treatment of a femoral VCD. It was demonstrated
that the common femoral artery and femoral bifurcation
were the most punctured access sites in the present co-
hort possibly revealing easiest anatomical accessibility.
Arterial punctures below the femoral bifurcation was
less performed. Accordingly, arterial puncture at the
Table 4 Bleedings according to heights of femoral arterial punctures
Common femoral artery
(n = 39)
Femoral bifurcation
(n = 37)
Low puncture
(n = 19)
p value
Overall bleedings, n (%) 24 (62) 15 (41) 11 (58) 0.163
Related to 5 F, ratio (%) 2/3 (67) 2/8 (25) 3/3 (100) 0.143
Related to 6 F, ratio (%) 22/36 (61) 13/29 (45) 8/16 (50) 0.409
BARC, n (%)
0 15 (38) 22 (60) 8 (42) 0.163
1 16 (41) 13 (35) 9 (47) 0.667
2 7 (18) 2 (5) 1 (5) 0.191
3A 0 (0) 0 (0) 0 (0) -
3B 1 (3) 0 (0) 1 (5) 0.677
3C 0 (0) 0 (0) 0 (0) -
4 0 (0) 0 (0) 0 (0) -
5 0 (0) 0 (0) 0 (0) -
TIMI, n (%)
0 15 (38) 22 (59) 8 (42) 0.163
1 24 (62) 15 (41) 11 (58) 0.163
2 0 (0) 0 (0) 0 (0) -
3 0 (0) 0 (0) 0 (0) -
GUSTO, n (%) 2 (5) 2 (5) 2 (11) 0.741
0 15 (39) 22 (60) 8 (42) 0.163
1 23 (59) 15 (41) 11 (58) 0.228
2 0 (0) 0 (0) 0 (0) -
3 1 (3) 0 (0) 0 (0) 1.000
FERARI, n (%)
0 15 (38) 22 (60) 8 (42) 0.163
1 12 (31) 8 (22) 5 (26) 0.663
2 6 (15) 6 (16) 1 (5) 0.487
3 5 (13) 1 (3) 3 (16) 0.143
4 1 (3) 0 (0) 2 (11) 0.101
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bifurcation revealed a numerically lowest amount of
bleedings (41%) compared to the CFA (62%) and lower
punctures (58%), without reaching statistical cut-off.
In contrast, lower arterial punctures could not be shown
to be associated with a worse outcome. It might me spec-
ulated whether a lower arterial puncture might be a valid
alternative puncture site without increasingly risking
bleedings.
No significant differences of baseline characteristics, indi-
cations of PCI and anticoagulation therapies were seen ac-
cording to the described femoral arterial puncture sites,
with the exception of a significantly higher number of fe-
male patients in the lower puncture group. This might indi-
cate, that female patients are more likely to be punctured
distally of the femoral bifurcation than male patients. Com-
paring female and male bleeding probabilities, no signifi-
cance was recorded in the present study, although former
studies have shown female gender having an increased
bleeding risk [9]. Therefore the high number of bleedings
in the lower puncture group might partially be a result of
the high percentage of female patients (63%). The BMI dif-
ferences might indicate that increased weight moves the
operator to perform arterial puncture more distally. Add-
itionally overweight and obese patients have lower bleeding
rates [15].
The extend of documented bleedings was rarely of se-
vere nature. Whether severe bleedings are associated simi-
larly by different arterial puncture sites therefore needs to
be investigated by large scale studies. The evaluation of
anticoagulation therapies did not show any significant dif-
ferences in each evaluated subgroup, making an uneven
influence on the observed bleedings unlikely.
Study limitations
Patients were included retrospectively in the FERARI
study after successful PCI and either VCD implantation
or radial compression bracelet usage and therefore pre-
selected and non-randomized. Only a single type of
VCD was used in this study. Unsuccessful VCD implan-
tations were not included into the FERARI study and
could therefore not be analysed. Follow up period was
limited to 30 days, which does not give any information
on long term effects. Finally, bleeding events were only
described clinically, without a standardized imaging
technique such as duplex sonography.
Conclusions
In conclusion, the present study suggests, that bleed-
ing risks associated with different punctured femoral
arterial sites does not differ significantly. Therefore,
neither CFA, femoral arterial bifurcation, nor pro-
found and superficial femoral artery might have
favoured the occurrence of bleeding. Weather the
statistical trend being observed for a less bleeding
rate at the femoral bifurcation is just statistical vari-
ance or due to a low study population needs to be
investigated within a larger prospective studies.
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